Thanks in part to market share gains and increasing demand for high-quality cannabis at an affordable price in Canada, Cannara Biotech Inc. (OTCMKTS: LOVFF), the vertically integrated producer of premium-grade cannabis and derivative product offerings, reported record growth in revenue and net income for its fourth quarter of 2023.
Cannara Biotech (CNSX:LOVE – Get Free Report) Senior Officer Nicholas Sosiak purchased 22,700 shares of the company’s stock in a transaction on Wednesday, November 30th. The shares were bought at an average price of $1.10 per share, with a total value of $24,970.00. Cannara Biotech Stock Performance About Cannara Biotech (Get Free Report) Cannara Biotech […]
MONTREAL, Dec. 11, 2023 /PRNewswire/ - Cannara Biotech Inc. , a vertically integrated producer of premium-grade cannabis and derivative products with one of the largest indoor cannabis.
Nicholas Sosiak, CFO of Cannara Biotech LOVE LOVFF 8CB was recently interviewed by Benzinga. Cannara is a vertically integrated producer of premium‐grade…